NORML argues that the hearing record will be incomplete unless it includes the perspective of adult cannabis consumers — the constituency NORML has represented for more than fifty years.
Tag: Donald Trump
“While we welcome any easing of federal policies that target and discriminate against cannabis consumers, this particular policy shift appears to be largely opportunistic and not in any way reflective of a broader shift in the federal government’s stance toward those who consume marijuana responsibly.”
“The integration of certain therapeutic cannabis products into the Medicare program further legitimizes the use of marijuana as a medicine, particularly for improving the health-related quality of life of older Americans and seniors.”
“These facts compel the federal government to recognize that marijuana can be legitimate in terms of medical applications.”
The following primer seeks to provide clarity to frequently asked questions surrounding cannabis rescheduling and its policy implications.
“While such a move potentially provides some benefits to patients, and veterans especially, it still falls well short of the changes necessary to bring federal marijuana policy into the 21st century.”
It’s been approximately one month since President Trump announced that the administration is “looking into” federally reclassifying cannabis and that it would “make a determination over the next few weeks.”
Absent cannabis descheduling, those who produce, dispense, possess, or use marijuana in compliance with state laws could still face federal prosecution for violating federal drug laws.